These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2453507)

  • 1. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746.
    Berliner S; Niiya K; Roberts JR; Houghten RA; Ruggeri ZM
    J Biol Chem; 1988 Jun; 263(16):7500-5. PubMed ID: 2453507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple epitope specificity of monoclonal antibodies to a single synthetic peptide: use in the characterization of the GP IIb-IIIa binding domain of von Willebrand factor.
    Berliner SA; Houghten RA; Roberts JR; Ruggeri ZM
    Adv Exp Med Biol; 1990; 281():133-44. PubMed ID: 1715119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules.
    Berliner SA; Roberts JR; Thorn ML; Ruggeri ZM
    Pept Res; 1988; 1(2):60-4. PubMed ID: 2485226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen.
    Abrams CS; Ruggeri ZM; Taub R; Hoxie JA; Nagaswami C; Weisel JW; Shattil SJ
    J Biol Chem; 1992 Feb; 267(4):2775-85. PubMed ID: 1370832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
    Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
    J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa.
    Piétu G; Ribba AS; Chérel G; Meyer D
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):711-5. PubMed ID: 1377911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism.
    Dejana E; Lampugnani MG; Giorgi M; Gaboli M; Federici AB; Ruggeri ZM; Marchisio PC
    J Cell Biol; 1989 Jul; 109(1):367-75. PubMed ID: 2545728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide.
    Charo IF; Nannizzi L; Phillips DR; Hsu MA; Scarborough RM
    J Biol Chem; 1991 Jan; 266(3):1415-21. PubMed ID: 1703149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex.
    Steiner B; Cousot D; Trzeciak A; Gillessen D; Hadváry P
    J Biol Chem; 1989 Aug; 264(22):13102-8. PubMed ID: 2753902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
    Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
    J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets.
    Huang TF; Holt JC; Kirby EP; Niewiarowski S
    Biochemistry; 1989 Jan; 28(2):661-6. PubMed ID: 2653425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T; Sadler JE
    J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
    Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
    Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inactivation of Von Willebrand factor binding to glycoprotein IIb/IIIa and to inhibitor monoclonal antibody 9 by site-directed mutagenesis.
    Jumilly AL; Veyradier A; Ribba AS; Meyer D; Girma JP
    Hematol J; 2001; 2(3):180-7. PubMed ID: 11920243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.
    Lawrence JB; Kramer WS; McKeown LP; Williams SB; Gralnick HR
    J Clin Invest; 1990 Nov; 86(5):1715-22. PubMed ID: 2243140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.